Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

OP 2507

Known as: OP-2507 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
AIM To examine whether antithrombin (AT) could prevent hepatic ischemia/reperfusion (I/R)-induced hepatic metastasis by… Expand
Is this relevant?
2001
2001
Leukocyte-endothelial adherence and changes of blood flow in microcirculation are associated with the development of ischemia… Expand
Is this relevant?
1998
1998
BACKGROUND Microcirculatory derangement, energy depletion, and lipid peroxidation are associated with the development of ischemia… Expand
Is this relevant?
1996
1996
We investigated the effect of a prostacyclin analogue (OP 2507) on PVG (RT1c) recipients subjected to an extended anhepatic phase… Expand
Is this relevant?
1994
1994
Abstract We investigated whether the stable prostacyclin analogue (OP‐2507; OP) would ameliorate warm ischemia‐related injury of… Expand
Is this relevant?
1992
1992
  • M. Tamura
  • Japanese circulation journal
  • 1992
  • Corpus ID: 23216860
The protective effects of the PGI2 analogue, OP-2507 against hypoxic tissue injury were investigated in a 60-70 min acute… Expand
Is this relevant?
1988
1988
We evaluated the inhibitory activity of a novel prostacyclin analog, OP-2507 (15-cis-(4-n-propylcyclohexyl)-16,17,18,19,20… Expand
Is this relevant?
1988
1988
Effects of OP-2507 [15-cis-(4-propylcyclohexyl)-16,17,18,19,20-pentanor-9-deoxy -9 alpha-nitrilo- PGF1 methylester] on cerebral… Expand
Is this relevant?
1988
1988
Synthesized was 15-cis-(4-n-propylcyclohexyl)-16, 17, 18, 19, 20-pentanor-9-deoxy-6, 9α-nitrilo-prostaglandin F1 methyl ester (OP… Expand
Is this relevant?
1986
1986
Protective effects of OP-2507 [15-cis-(4-propylcyclohexyl)-16,17,18,19,20-pentanor-9-deoxy -9 alpha, 6-nitrilo-PGF1 methyl ester… Expand
Is this relevant?